Carivalan is indicated as substitution therapy in adult patients with normal sinus rhythm already controlled by ivabradine and carvedilol taken concomitantly at the same doses level for: the symptomatic treatment of chronic stable angina pectoris in coronary artery disease patients; the treatment of chronic heart failure (II-IV NYHA-class) with systolic dysfunction.